Hypercalcemia and cancer: Differential diagnosis and treatment

Research output: Contribution to journalReview articlepeer-review

96 Scopus citations

Abstract

Incidentally detected hypercalcemia usually presents in an indolent manner and is most likely caused by primary hyperparathyroidism. In contrast, hypercalcemia in the patient with a history of cancer presents in a wide range of clinical settings and may be severe enough to warrant hospitalization. This form of hypercalcemia is usually secondary to hypercalcemia of malignancy and can be fatal. Hypercalcemia of malignancy is most commonly mediated by tumoral production of parathyroid hormone–related protein or by cytokines activating osteoclast degradation of bone. The initial workup, differential diagnoses, confirmatory laboratory testing, imaging, and medical and surgical management of hypercalcemia are described in the patient with cancer.

Original languageEnglish (US)
Pages (from-to)377-386
Number of pages10
JournalCA Cancer Journal for Clinicians
Volume68
Issue number5
DOIs
StatePublished - Sep 1 2018

Keywords

  • evaluation
  • malignancy
  • management
  • paraneoplastic syndrome

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Hypercalcemia and cancer: Differential diagnosis and treatment'. Together they form a unique fingerprint.

Cite this